This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands

Title N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands
Abstract

Two series of N-(heteroaryl)thiophene sulfonamides, encompassing either a methylene imidazole group or a tert-butylimidazolylacetyl group in the meta position of the benzene ring, have been synthesized. An AT 2 R selective ligand with a K i of 42 nM was identified in the first series and in the second series, six AT 2 R selective ligands with significantly improved binding affinities and K i values of 2 R were explored by docking calculations combined with molecular dynamics simulations. Although some of the high affinity ligands exhibited fair stability in human liver microsomes, comparable to that observed with C21 undergoing clinical trials, most ligands displayed a very low metabolic stability with t ½ of less than 10 min in human liver microsomes. The most promising ligand, with an AT 2 R K i value of 4.9 nM and with intermediate stability in human hepatocytes (t ½ = 77 min) caused a concentration-dependent vasorelaxation of pre-contracted mouse aorta.

Apa Reference Wannberg, J., Gising, J., Henriksson, M., Vo, D.D., Sävmarker, J., Sallander, J., Gutiérrez-de-Terán, H., Larsson, J., Hamid, S., Ablahad, H., Spizzo, I., Gaspari, T.A., Widdop, R.E., Grönbladh, A., Petersen, N.N., Backlund, M., Hallberg, M. & Larhed, M. (2024). N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands. European Journal of Medicinal Chemistry, 265, 116122. 10.1016/j.ejmech.2024.116122
Doi 10.1016/j.ejmech.2024.116122
Publication Date Feb 2024
Publication Type Article
Researcher Hugo Gutiérrez de Terán Castañón
Ontology Computational models and simulations, FAIRfication, Biomolecular simulation, Molecular Interactions/Docking
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home